Vir Biotechnology Inc - ESG Rating & Company Profile powered by AI
The Sustainability assessment for Vir Biotechnology Inc represents the company's transparency towards the United Nations SDGs. If you are employed by Vir Biotechnology Inc and you would like to licence your Sustainability rating, please get in touch. The report of Vir Biotechnology Inc uses data from across the web and also from available disclosures by Vir Biotechnology Inc.
Vir Biotechnology Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.1; made up of an environmental score of 5.3, social score of 3.4 and governance score of 6.7.
5.1
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 687 | Valbiotis SA | 5.2 | High |
| 687 | Zeria Pharmaceutical Co Ltd | 5.2 | High |
| 724 | Vir Biotechnology Inc | 5.1 | High |
| 724 | Catalyst Pharmaceuticals Inc | 5.1 | High |
| 724 | Adverum Biotechnologies Inc | 5.1 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Vir Biotechnology Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Vir Biotechnology Inc report the average age of the workforce?
Sign up for free to unlockDoes Vir Biotechnology Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Vir Biotechnology Inc offer flexible work?
Sign up for free to unlockDoes Vir Biotechnology Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Vir Biotechnology Inc conduct supply chain audits?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Vir Biotechnology Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose water use targets?
Sign up for free to unlockDoes Vir Biotechnology Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Vir Biotechnology Inc have a product recall in the last two years?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Vir Biotechnology Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Vir Biotechnology Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose parental leave metrics?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Vir Biotechnology Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Vir Biotechnology Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Vir Biotechnology Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose its waste policy?
Sign up for free to unlockDoes Vir Biotechnology Inc report according to TCFD requirements?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose energy use targets?
Sign up for free to unlockDoes Vir Biotechnology Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Vir Biotechnology Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Vir Biotechnology Inc
These potential risks are based on the size, segment and geographies of the company.
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; and VIR-1111 for the prevention of human immunodeficiency virus. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited and Brii Biosciences Offshore Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with The Rockefeller University and MedImmune, Inc.; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies; and clinical collaboration with Gilead Sciences, Inc. for chronic hepatitis B virus. Vir Biotechnology, Inc. was incorporated in 2016 and is headquartered in San Francisco, California.